BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Schrödinger

Schrödinger logo

Founded
1990
Geography
United States of America based
Funding
$799.225 M

Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas.
Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990, has over 400 employees, and is engaged with customers and collaborators in more than 70 countries


molecular modeling

Technologies

AI Companies (Drug Discovery)   Pharmaceutical and Drug Discovery   Quantum Theory in Drug Discovery  


Posts Mentioning This Company

R&D Platform

Docking/fitting prediction, a range of computational chemistry tools, new to DL


Pipelines

None
Preclinical  |  Visit website

Our world-class drug discovery team is leveraging our computational platform and massive computing power to advance our preclinical pipeline and a portfolio of programs in collaboration with leading biotech and pharmaceutical companies.

Products

 

Services

No services posted yet